You searched for "Audiology"

2126 results found

Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL

Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...

Immunosuppresants and ototoxicity

There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...

Is bone cement a cost-effective solution?

This study looks at the functional results of 52 patients who underwent bone cement ossiculoplasty. Patients were divided into four groups based on ossicular disruption. Group 1 (30 patients) had lenticular erosion only. Group 2 (13 patients) had absent incus....

French clinic prize for Chloe Swords

Congratulations to Chloe Swords for winning the TWJ Short Papers Presentation Prize for 2023 for her presentation at the Royal Society of Medicine (RSM), London, UK. She is seen here being presented with her prize of a trip to the Jean Causse Clinic in Béziers, France, by Martin Bailey, Consultant ENT Surgeon.

High dose betahistine as effective as, but slower acting compared to intratympanic dexamethasone in intractable Meniere’s disease

The management of intractable Meniere’s disease poses a complex conundrum to otolaryngologists. The focus of treatment is decreasing the severity and frequency of vertigo and tinnitus whilst trying to preserve hearing. Betahistine has been used for many years in the...

Cochlear implants in the over 80s

The UK has an ageing population. Seven percent of the over 80s population have bilateral severe to profound hearing loss which can lead to associated negative outcomes (social isolation, depression and reduced quality of life). Cochlear implantation (CI) can successfully...

Semicircular canal dehiscence and cochlear implantation

Semicircular canal dehiscence (SCD) is thought to occur in 3% of the population, it is mostly asymptomatic, but patients may present with sound-induced vestibular symptoms, low-frequency conductive hearing loss, autophony, hyperacusis and aural fulness. With the increasing utilisation of cochlear...

Cambodian otology service – a fellowship with a difference

Cambodia is a country of 15 million people, still recovering from a chequered past. In the 1970s, under the Khmer Rouge, most of the medical profession, together with the rest of the educated population, was executed – the fortunate few...

Clinical WG1. Establishing a standard for tinnitus: patient assessment and characterisation

Rilana Cima and Haúla Haider introduce an ambitious pan-European collaboration that seeks to establish guidelines for achieving best clinical practice for managing, assessing and treating patients with different tinnitus profiles. Tinnitus heterogeneity is the major reason for inconsistent results in...

HearAdvisor’s scientific and consumer-friendly approach to evaluating hearing aids

An ageing population means more hearing aid users. The authors of this article describe their techniques for independently assessing prescription and over-the-counter hearing aids in an acoustic laboratory. As the role of consumers in the hearing aid purchasing decision continues...

OBITUARY: Professor Vittorio Colletti (1943–2024)

After a long illness, Professor Vittorio Colletti, born in 1943, passed away on 2 January 2024 at the age of 80.

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.